Pharma News

Keep updating your pharma knowledge
12 May 2015

Rusan Healthcare India’s first fully indigenous nicotine patch 2baconil™

India’s first fully indigenous nicotine patch 2baconil was recently launched by Rusan Healthcare Pvt Ltd, a marketing arm of the parent company Rusan Pharma Ltd, which is a global pharmaceutical company with interests in R&D, Manufacturing and Marketing of formulations, APIs and their intermediates. With 270 million Indians addicted to tobacco in one form or the other, with the launch of 2baconil™ patches a new form of Nicotine Replacement Therapy (NRT) is now available in India to the doctors and patients seeking treatment for tobacco de-addiction.

As per company’s product claim – “2baconil™ offers several advantages for people trying to quit. It reduces withdrawal symptoms, allowing the smoker to focus on the psychological aspects of quitting. So don’t forget to speak to your loved ones or a doctor, to help you boost your morale. You’re taking a RIGHT and COOLER Decision by QUITTING!”

2baconil™ is a unique patch with Smart TimeRelease™ Technology that helps prevent the urge to smoke all day long.* 2baconil™ supports you through your day by delivering remedial nicotine via the patch’s specially designed layers. This technology ensures a steady and all day release, so that the nicotine in the patch will not be delivered all at once, or run out too soon. 2baconil™ will help you overcome the side effects associated with & most importantly early morning cravings*

Leave a Reply

The reCAPTCHA verification period has expired. Please reload the page.

Upskill Your Pharma Knowledge

Explore Next Gen Learning

Case Studies & Caselets | Simulation Based Learning | E-Lectures | Online Self Competency Assessments

Thank You for Subscription!